Tolerability and efficacy of aripiprazole in patients with first-episode schizophrenia: An open-label pilot study

被引：0
|
作者：
Saha, AR
Brown, D
McEvoy, J
Ali, M
Abou-Gharbia, N
Stock, E
机构：
[1] Otsuka Maryland Res Inst, Rockville, MD USA
[2] Bristol Myers Squibb Co, Princeton, NJ USA
[3] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[4] Community Clin Res Inc, Austin, TX USA
[5] Duke Univ, Dept Psychiat & Behav Sci, John Umstead Hosp, Butner, NC USA
来源：
SCHIZOPHRENIA RESEARCH | 2004年 / 67卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [1] Efficacy and Tolerability of Aripiprazole in First-Episode Drug-Naive Patients With Schizophrenia: An Open-Label Trial
    Takahashi, Hitoshi
    Oshimo, Takashi
    Ishigooka, Jun
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (03) : 149 - 150
  • [2] One-year open-label study of the cognitive efficacy of blonanserin in antipsychotic-naive first-episode schizophrenia
    Miyamoto, S.
    Tenjin, T.
    Miyake, N.
    Ojima, K.
    Ninomiya, Y.
    Kitajima, R.
    Ogino, S.
    Kaneda, Y.
    Sumiyoshi, T.
    Yamaguchi, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 57 - 58
  • [3] THE OPTIMISE STUDY: AMISULPRIDE AND OLANZAPINE FOLLOWED BY OPEN-LABEL TREATMENT WITH CLOZAPINE IN FIRST-EPISODE SCHIZOPHRENIA
    Arango, Celso
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S115 - S115
  • [4] An open-label study of olanzapine in the first episode of schizophrenia in adolescents
    Dabokowska, M
    EUROPEAN PSYCHIATRY, 2002, 17 : 115S - 115S
  • [5] Efficacy and Tolerability of Ziprasidone vs. Olanzapine in Naive First-Episode Schizophrenia: A 6-Week, Randomized, Open-Label, Flexible-Dose Study
    Li, Y. -M.
    Zhao, J. -P.
    Ou, J. -J.
    Wu, R. -R.
    PHARMACOPSYCHIATRY, 2012, 45 (05) : 177 - 181
  • [6] An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders
    Yoo, Hanik K.
    Choi, Soon-Ho
    Park, Subin
    Wang, Hee-Ryung
    Hong, Jin-Pyo
    Kim, Chang-Yoon
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (07) : 1088 - 1093
  • [7] An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes
    Cheng, Zhang
    Yuan, Yanbo
    Han, Xue
    Yang, Lei
    Cai, Shangli
    Yang, Fude
    Lu, Zheng
    Wang, Chuanyue
    Deng, Hong
    Zhao, Jingping
    Xiang, Yutao
    Correll, Christoph U.
    Yu, Xin
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (10) : 1227 - 1236
  • [8] An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine
    Virgilio Gallai
    Andrea Alberti
    Cristiana Rossi
    Francesca Coppola
    Beatrice Gallai
    Giovanni Mazzotta
    Paola Sarchielli
    The Journal of Headache and Pain, 2003, 4 (2) : 92 - 96
  • [9] Efficacy and tolerability of long-term (up to 5 years) open-label treatment with aripiprazole in schizophrenia
    Carson, W
    Ali, M
    Saha, A
    McQuade, R
    Owen, R
    Stock, E
    Yamamoto, Y
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S510 - S510
  • [10] Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naive patients with schizophrenia: a randomized controlled open-label study
    Lang, Xiaoe
    Xue, Mei
    Zang, Xiaocui
    Wu, Fengchun
    Xiu, Meihong
    Zhang, Xiangyang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
12345